Acta Scientific Microbiology (ISSN: 2581-3226)

Research Article Volume 5 Issue 12

Evaluation of Hemodynamics and Oxidative Stress in the Pathophysiology of L-NAME Induced Preeclampsia in Rats

Huma Quasimi1, Shazli Naaz1, Neha Dhyani2, Saumya Bhagat3, GA Khan4, Mairaj Ansari5 and Md Iqbal Alam1*

1Department of Physiology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi, India

2Department of Cellular and Integrative Physiology, University of Nebraska Medical Centre, Omaha, USA

3Division of Bone and Mineral Disease, Washington University, School of Medicine, St. Louis, USA

4Department of Clinical Nutrition, College of Applied Medical Sciences, King Faisal University, Alhasa, KSA

5Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India

*Corresponding Author: Md Iqbal Alam, Professor, Department of Physiology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi, India.

Received: October 25, 2022; Published: November 21, 2022

Abstract

Background: Preeclampsia (PE) is a serious pregnancy disorder that accounts for 4-5% of fetal and maternal mortality and morbidity worldwide. It is imperative to understand the pathophysiology of PE to devise an effective therapy or cure for PE. In this study, we aim to characterize an animal model of PE and evaluate the hemodynamic changes and oxidative stress in PE.

Methods: Systolic and diastolic blood pressure, mean arterial pressure, and heart rate were recorded invasively along with proteinuria on the 21st day of gestation in an NG-nitro-L-arginine-methyl-ester (L-NAME) induced animal model and by phenotypic characteristics were accounted for. Alanine aminotransferase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP) levels were measured. Cardiac abnormalities were confirmed by electrocardiography and creatinine-kinase (CK) levels. Plasma concentrations of nitric oxide, reactive oxygen species (ROS), and antioxidants were measured.

Results: The hemodynamic parameters and proteinuria were found to be elevated in the PE group as compared to the other groups. The animal model was validated by phenotype characterization. We observed ST elevation and increased p-wave dispersion (Pd) and CK-MB levels. In PE groups, plasma levels of AST, ALT, and ALP were significantly higher. Significantly increased levels of ROS and decreased levels of antioxidants were observed. The results are significant with a p-value <0.05.

Conclusion: The L-NAME-induced animal replicates most of the clinical symptoms of PE. It may be used to study the pathophysiological aspects of preeclampsia, especially the effects on the maternal heart. Here, a rat model is used for the first time to show Pd, ST elevation, and cardiac hypertrophy.

Keywords: Preeclampsia; L-NAME; Oxidative Stress; Hemodynamics; ECG; Biochemical Tests

References

  1. AB Wallis., et al. “Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004”. American Journal of Hypertension 21 (2008): 521-526.
  2. EG Mulder., et al. “Hypertension Preventing Recurrent Preeclampsia by Tailored Treatment of Nonphysiologic Hemodynamic Adjustments to Pregnancy”. Hypertension 77 (2021): 2045-2053.
  3. Prof E A P Steegers MD, J.J.D.M. Department, of O. and Gynaecology, U. of B. Columbia, C. Vancouver, BC, (P von Dadelszen MBChB); And, D. of O. And, C. Gynaecology, U. of Leuven, U. Hospital, B. Gasthuisberg, Leuven, (Prof R Pijnenborg PhD), Pre-eclampsia. Lancet 376 (2010): 631-44.
  4. Bc. Esther Frances Davis., et al. “Cardiovascular Risk Factors in Children and Young Adults Born to Preeclamptic Pregnancies: A Systematic Review”. Pediatrics 129 (2012): e1552-e1561.
  5. L Bellamy., et al. “Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis”. British Medical Journal 335 (2007): 974-977.
  6. E Kajantie., et al. “Pre-eclampsia is associated with increased risk of stroke in the adult offspring the helsinki birth cohort study”. Stroke 40 (2009): 1176-1180.
  7. AL Tranquilli., et al. “The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP”. Pregnancy Hypertens 4 (2014): 97-104.
  8. M Hu and J Li. “Revisiting preeclampsia : a metabolic disorder of the placenta”. 289 (2022): 336-354.
  9. S Gupta., et al. “The role of placental oxidative stress and lipid peroxidation in preeclampsia”. Obstetrical and Gynecological Survey 60 (2005): 807-816.
  10. C Maric-Bilkan., et al. “Research recommendations from the national institutes of health workshop on predicting, preventing, and treating preeclampsia”. Hypertension 73 (2019): 757-766.
  11. JL Sones and RL Davisson. “Preeclampsia, of mice and women”. Physiology Genomics 48 (2016): 565-572.
  12. W Shu., et al. “Evaluation of blood vessel injury, oxidative stress and circulating inflammatory factors in an l-name-induced preeclampsia-like rat model”. Experimental and Therapeutic Medicine 16 (2018): 585-594.
  13. MW Radomski., et al. “The Biological And Pharmacological Role Of Nitric Oxide In Platelet Function”. Advances in Experimental Medicine and Biology (1993): 251-252.
  14. S Yang., et al. “Ameliorative effects of pre-eclampsia by quercetin supplement to aspirin in a rat model induced by L-NAME”. Biomedicine and Pharmacotherapy 116 (2019): 108969.
  15. E Aksu., et al. “Cardiac electrical and structural alterations in preeclampsia”. Journal of Maternal-Fetal and Neonatal Medicine 35 (2022): 1-10.
  16. Y Zhao., et al. “Systemic evaluation of vascular dysfunction by high-resolution sonography in an Nω-nitro-l-arginine methyl ester hydrochloride-induced mouse model of preeclampsia-like symptoms”. Journal of Ultrasound in Medicine 37 (2018): 657-666.
  17. MM Ziganshina., et al. “Hyaluronic acid in vascular and immune homeostasis during normal pregnancy and preeclampsia”. Acta Naturae 8 (2016): 59-71.
  18. N Dhyani., et al. “Fenofibrate ameliorates neural, mechanical, chemical, and electrical alterations in the murine model of heart failure”. Human and Experimental Toxicology 38 (2019): 1183-1194.
  19. LF Van Pelt. “Ketamine and xylazine for surgical anesthesia in rats”. 171 (1977): 842-844.
  20. IA Care and U Committee. “WVU IACUC POLICY : Euthanasia by Decapitation or Cervical Dislocation”. (2021): 1-3.
  21. B Singh., et al. “Von willebrand factor antagonizes nitric oxide synthase to promote insulin resistance during hypoxia”. Biochemistry 53 (2014): 115-126.
  22. H Ohkawa., et al. “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction”. Analytical Biochemistry 95 (1979): 351-358.
  23. S Marklund and G Marklund. “Involvement of the Superoxide Anion Radical in the Autoxidation of Pyrogallol and a Convenient Assay for Superoxide Dismutase”. European Journal of Biochemistry 47 (1974): 469-474.
  24. GL Ellman. “Tissue Su ~ yd ~ l Groups” (1959): 70-77.
  25. Z Stanley., et al. “Extreme elevations of alkaline phosphatase in pregnancy: A case report”. Case Reports Women’s Health 27 (2020): e00214.
  26. M Vechoropoulos., et al. “The proatherogenic effect of chronic nitric oxide synthesis inhibition in ApoE-Null mice is dependent on the presence of PPAR α”. PPAR Research 2014 (2014).
  27. Y Wang., et al. “Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats”. Clinical and Experimental Hypertension 39 (2017): 628-639.
  28. QN Dinh., et al. “Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension”. BioMed Research International 2014 (2014).
  29. A Ahmed., et al. “A new mouse model to explore therapies for preeclampsia”. PLoS One 5 (2010): 1-9.
  30. A Dawood Darbar., et al. “P Wave Signal-Averaged Electrocardiography to Identify Risk for Atrial Fibrillation”. Pacing and Clinical Electrophysiology 25 (2002): 1447-1453.
  31. PR Romundstad., et al. “Hypertension in pregnancy and later cardiovascular risk: Common antecedents?”. Circulation 122 (2010): 579-584.
  32. , et al. “P-wave duration changes and dispersion in preeclampsia”. European Journal of Obstetrics and Gynecology and Reproductive Biology 183 (2014): 141-145.
  33. R Dacaj., et al. “Elevated Liver Enzymes in Cases of Preeclampsia and Intrauterine Growth Restriction”. Medical Archives (Sarajevo, Bosnia Herzegovina). 70 (2016): 44-47.
  34. J Li., et al. “A model of preeclampsia in rats: The reduced uterine perfusion pressure (RUPP): model”. The American Journal of Physiology-Heart and Circulatory Physiology 303 (2012).
  35. A Beauséjour., et al. “Placental Oxidative Stress in a Rat Model of Preeclampsia”. Placenta 28 (2007): 52-58.
  36. S Caluwaerts., et al. “Endovascular trophoblast invasion and associated structural changes in uterine spiral arteries of the pregnant rat”. Placenta 26 (2005): 574-584.
  37. CA Hubel. “Oxidative stress in the pathogenesis of preeclampsia”. Experimental Biology and Medicine 222 (1999): 222-235.
  38. DT Lowe. “Nitric Oxide Dysfunction in the Pathophysiology of Preeclampsia”. 4 (2000): 441-458.
  39. T Johal., et al. “The nitric oxide pathway and possible therapeutic options in pre-eclampsia”. (2013).

Citation

Citation: Md Iqbal Alam., et al. “Evaluation of Hemodynamics and Oxidative Stress in the Pathophysiology of L-NAME Induced Preeclampsia in Rats". Acta Scientific Microbiology 5.12 (2022): 75-84.

Copyright

Copyright: © 2022 Md Iqbal Alam., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is February 15, 2023.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US